FDA Requests Comments on Proposed Collection of Information for Automated Blood Cell Separator Device

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to the development of draft guidance for industry and FDA staff on Class II special controls for automated blood cell separator devices, which operate by centrifugal or filtration separation principle.